期刊
ONCOTARGET
卷 8, 期 49, 页码 85068-85084出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.18844
关键词
ACKR3; CXCR4; chemokine; B cell; lymphoma
资金
- Krebsforschung Schweiz [KFS 2891-02-2012]
- Swiss National Science Foundation [310030_163336]
- Helmut Horten Foundation
- Gelu Foundations
- Swiss National Science Foundation (SNF) [310030_163336] Funding Source: Swiss National Science Foundation (SNF)
Diffuse large B cell lymphoma (DLBCL) is the most frequent lymphoma accounting for more than the 30% of the cases. Involvement of extranodal sites, such as bone marrow and central nervous system, is associated with poor prognosis. A contribution of the chemokine system in these processes is assumed as it is known as a critical regulator of the metastatic process in cancer. The atypical chemokine receptor 3 (ACKR3), which does not couple to G-proteins and does not mediate cell migration, acts as a scavenger for CXCL11 and CXCL12, interfering with the tumor homing CXCL12/CXCR4 axis. Here, functional expression of ACKR3 in DLBCL cells was necessary for colonization of the draining lymph node in an in vivo subcutaneous lymphoma model. Moreover, in a disseminated in vivo lymphoma model, ACKR3 expression was required for bone marrow and brain invasion and local tumor growth. The present data unveil ACKR3 as potential therapeutic target for the control of tumor dissemination in DLBCL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据